News 2024-07-07
Porton Newsletter | Q2 2024 Recap
Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia.
Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR.
Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.
Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR.
Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
